Safety and Efficacy Clinical Trials for SYL1001, a Novel Short Interfering RNA for the Treatment of Dry Eye Disease. [electronic resource]
Producer: 20170623Description: 6447-6454 p. digitalISSN:- 1552-5783
- Adolescent
- Adult
- Dose-Response Relationship, Drug
- Double-Blind Method
- Dry Eye Syndromes -- diagnosis
- Female
- Humans
- Male
- Ophthalmic Solutions -- administration & dosage
- Prospective Studies
- RNA, Small Interfering -- administration & dosage
- TRPV Cation Channels -- drug effects
- Tears -- drug effects
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.